Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

This publication has 50 references indexed in Scilit:

• Emerging cytokine networks in colorectal cancer
  Nature Reviews Immunology, 2015
• Cancer-related inflammation and treatment effectiveness
  The Lancet Oncology, 2014
• Master regulator of intestinal disease: IL-6 in chronic inflammation and cancer development
  Seminars in Immunology, 2014
• Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
  Pharmacology & Therapeutics, 2014
• Microenvironmental regulation of tumor progression and metastasis
  Nature Medicine, 2013
• A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer
  British Journal of Cancer, 2012
• The cancer genome
  Nature, 2009
• IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
  Cancer Cell, 2009
• Pre-analytical and biological variability in circulating interleukin 6 in healthy subjects and patients with rheumatoid arthritis
  Biomarkers, 2008
• Multicenter Phase II Study of Nordic Fluorouracil and Folinic Acid Bolus Schedule Combined With Oxaliplatin As First-Line Treatment of Metastatic Colorectal Cancer
  Journal of Clinical Oncology, 2004